Search Results

The National Cardiogenic Shock Initiative

Dr. William W. O'Neill shares his experience with launching this initiative at both the regional and national levels.

With William W. O'Neill, MD, MSCAI, and Michael J. Lim, MD

Interventional Therapies for Heart Failure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

MitraClip: Path to Approval and Future Directions

An overview of the key features, clinical use, and potential hurdles for this percutaneous mitral valve repair system.

By Ted E. Feldman, MD, MSCAI, FACC, FESC; Michael H. Salinger, MD, FACC, FSCAI; Justin P. Levisay, MD, FACC, FSCAI; and Carl Tommaso, MD, FACC, MSCAI

Transcatheter Valve Implantation for Calcific Mitral Stenosis

TMVR with aortic THV devices might evolve into an acceptable alternative for selected patients with severe mitral annular calcification.

By Mayra Guerrero, MD; Dee Dee Wang, MD; Amit Pursnani, MD; Adam Greenbaum, MD; Michael Salinger, MD; Marvin Eng, MD; William O'Neill, MD; and Ted E. Feldman, MD

Aortic Valve Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

Transcatheter Mitral Valve Repair: For Whom Is It Still Better Than Replacement?

Current transcatheter options for mitral valve intervention.

By Faeez M. Ali, MD, DM, MRCP (UK), and Neil P. Fam, MD, MSc

Mechanisms of Transcatheter Valve Degeneration

A translational perspective.

By Hacina Gill, BSc; David Meier, MD; Althea Lai, BSc; Geoffrey W. Payne, MSc, PhD; and Stephanie L. Sellers, MSc, PhD

Contemporary Mitral Transcatheter Edge-to-Edge Repair

For successful TEER, a nuanced patient and device selection strategy that takes into account anatomy, clinical factors, and imaging is crucial.

By Loai Almazroa, MD, FRCPC, and Neil P. Fam, MD, MSc

Aortic and Mitral Valves

By Ted E. Feldman, MD, FSCAI

Management of No Reflow and Thrombus

A panel of experts share clinical scenarios, treatment approaches, challenges, and more.

With Jasleen Tiwana, MD; Blake Charlton, MD, FACC, FSCAI; Jesse A. Kane, MD; and Kalaivani Mahadevan, MD